Literature DB >> 3674096

Elevated pyruvate kinase activity in patients with hemolytic anemia due to red cell pyruvate kinase "deficiency".

E Beutler1, L Forman, E Rios-Larrain.   

Abstract

Two patients with non-spherocytic hemolytic anemia were found to have elevated red blood cell pyruvate kinase activities commensurate with the decreased mean red cell age, but the residual pyruvate kinase had marked kinetic abnormalities. Accumulation of metabolic intermediates before pyruvate kinase and reduced levels of activity of the red blood cells of the parents of both patients supported the diagnosis of an inherited abnormal pyruvate kinase causing hemolytic anemia. Although it was observed in two unrelated persons, review of enzyme assays performed on the red blood cells of 651 patients with hereditary non-spherocytic hemolytic anemia suggests that this occurrence is rare.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3674096     DOI: 10.1016/0002-9343(87)90648-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  G6PD Huntsville: a new glucose-6-phosphate dehydrogenase associated with chronic hemolytic anemia.

Authors:  K Hall; M T Schreeder; J T Prchal
Journal:  Hum Genet       Date:  1988-05       Impact factor: 4.132

2.  Heterozygous pyruvate kinase deficiency and severe hemolytic anemia in a pregnant woman with concomitant, glucose-6-phosphate dehydrogenase deficiency.

Authors:  J L Vives Corrons; A M García; A M Sosa; A Pujades; D Colomer; M Linares
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

3.  Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia.

Authors:  L Baronciani; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

Review 4.  Erythrocyte pyruvate kinase deficiency: 2015 status report.

Authors:  Rachael F Grace; Alberto Zanella; Ellis J Neufeld; D Holmes Morton; Stefan Eber; Hassan Yaish; Bertil Glader
Journal:  Am J Hematol       Date:  2015-08-14       Impact factor: 10.047

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.